Smart Lab, Automation and Technology US

Embracing the Technology-Led Future of Pharma and Biotech R&D

14 September 2021   |    EDT TIMEZONE

Increasing competition, the need to accelerate time-to-market for therapeutics, and new ways of working is forcing the biopharmaceutical industry to rethink how and where to conduct research. Traditionally, the industry has built customized “mono-purpose” labs with long lead times and significant capital expenditures, which makes it difficult to pivot or adapt to unanticipated changes in R&D demands, shifts or delays in the pipeline, drug failures, the impact of M&A, and unexpected opportunities.


This Virtual Roundtable will examine the challenges and costs BioPharma faces when pivoting to the unexpected and the specific role that infrastructure can play in providing solutions.

This event will provide you with the necessary tools to:

  • Drive lab digitalization and implement emerging technology solutions at scale
  • Assess the value proposition for lab automation and develop a roadmap for successful implementation
  • Digitally optimize your laboratory workflows to drive efficiency, productivity and quality gains
  • Create and implement an effective data quality and analytics strategy which facilitates improved decision-making and accelerates drug discovery and research
  • Manage the mindset and culture shift required for digital empowerment and successful transition to end-to-end laboratory automation
  • Align your strategy with the evolving vendor landscape to create strong partnership-driven relationships with solutions providers
  • Achieve enhanced cross-functional scientific collaboration with optimized smart lab connectivity

Smart Labs, Automation & Technology - Agenda

Tuesday 16 November 2022


07:55 – 08:00 Opening Remarks from AMG World


08:00 – 09:00 Unlocking the True Potential of IoLT (Internet of Laboratory Things)


Brian Arey, Senior Director Leads Discovery and Optimization, Bristol Myers Squibb
Terryl Kibodeaux, Director, R&D Business Relationship Management, Regeneron
Abhishek Mathur, Director, Global Research (Biologics), Amgen
Mary Belfast, Senior Scientist, Automation Manager, Teva Pharmaceuticals
Tuyen Nguyen, Senior Scientist, Alnylam Pharmaceuticals
Boris Brumshtein, Senior Research Scientist, Gilead



09:05 – 09:35 Achieving Lab Automation: The Complete 360° Lifecycle of Successful Lab Automation

Aude Smeets, Global Quality Control, Innovation Analytical Technical Expert Automation,
Vaccines, GSK
Vanessa Jully, Senior Manager, Technical R&D Automation Lead, GSK



09:40 – 10:00 Technology Demonstrations



10:00 – 10:30 Networking Break and Virtual Exhibition



10:30 – 11:00 Future Smart Labs: Leveraging Advanced Robotics & End-to-End Automation in the Lab



11:05 – 11:35 The Automation of Lab Data: Harnessing Scientific Data for Efficient, Compliant and
Technologically Optimized Labs of the Future


11:40 – 12:15 Networking Lunch and Virtual Exhibition



12:15 – 13:15 Embracing the Technologically Optimized Future of Pharma Experimentation, Discovery and R&D

Moiz Diwan, Director, Head of Enabling Technology Group, Abbvie
Jason Ekert, Senior Director, Fellow and Head of Complex In Vitro Models In Vitro/In Vivo
Translation, GSK
Szczepan Baran, Head of Emerging Technologies, Comparative Medicine, SO, Novartis
Martin Trapecar, Professor of Medicine, John Hopkins University

13:20 Close of the conference

Who Should Attend:

Smart Labs, Automation & Technology US 2021 is designed for VP’s, Directors, Heads and Managers from:


  • Automation / Robotics
  • R&D
  • Lab IT/ Research IT
  • Informatics
  • Technology & Innovation
  • Quality Assurance / Quality Control
  • Laboratory Operations & Strategy
  • Regulation, Compliance & Validation
  • Data & Analytics
  • Industry 4.0 / Lab 4.0
  • Emerging Technology / Artificial Intelligence (AI) / Machine Learning (ML)

Our sponsors include technology, service & solution providers specializing in:


  • Laboratory Automation / Lab Digitalization
  • Robotics
  • Informatics
  • Data & Analytics
  • Artificial Intelligence (AI) / Machine Learning (ML)
  • Cloud Computing
  • IoT Hardware, Software, Platforms, Infrastructure
  • Cyber Security


Sponsorship Opportunities:

Recent disruption has continued to re-shape the conventional approach to networking, creating an opportunity to continue business within a virtual setting.


Our attendees are actively working through their operational and transformational challenges, but they also require support from dedicated solution providers who can offer guidance, expertise and technology to help solve unique business problems.


It is critical that the vendor community continues to support their customers through open discussions and information exchange; as well as nurture existing relationships and building a pipeline of new and valuable leads.


For more information on how we are uniquely placed to help you shape and deliver your message to your target audience, contact us now!


Simon Wright
Commercial Director